- Hsa-miRNA-143-3p Reverses Multidrug Resistance of Triple-Negative Breast Cancer by Inhibiting the Expression of Its Target Protein Cytokine-Induced Apoptosis Inhibitor 1 In Vivo
-
Deng YW, Hao WJ, Li YW, Li YX, Zhao BC, Lu D
- KMID: 2421365
- J Breast Cancer.
- 2018 Sep;21(3):251-258.
- doi: 10.4048/jbc.2018.21.e40
PURPOSE: Multidrug resistance (MDR) remains a major obstacle in the treatment of triple-negative breast cancer (TNBC) with conventional chemotherapeutic agents. A previous study demonstrated that hsa-miRNA-143-3p plays a vital role... -
- CITED
-
- Close
- SHARE
-
- Close
